Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis

Clinical Cancer Research

Volumn 15, Issue 17, 2009, Pages 5485-5493

  Hu, Hai ^a   Sun, Lichao ^a   Guo, Chunguang ^a   Liu, Qian ^a   Zhou, Zhuan ^a   Peng, Liang ^a   Pan, Jian ^a   Yu, Long ^a   Lou, Jinning ^b   Yang, Zhihua ^a   Zhao, Ping ^a   Ran, Yuliang ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; SYNUCLEIN; SYNUCLEIN G; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; MARKER GENE; MICROARRAY ANALYSIS; MICROENVIRONMENT; MOUSE; NONHUMAN; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR CELL; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CELL LINE, TUMOR; CHEMOKINE CCL2; COCULTURE TECHNIQUES; COLORECTAL NEOPLASMS; FEMALE; GAMMA-SYNUCLEIN; HUMANS; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SENSITIVITY AND SPECIFICITY; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 69949092197     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-2491     Document Type: Article

References (44)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. McMillan DC, McArdle CS. Epidemiology of colorectal liver metastases. Surg Oncol 2007;16:3-5.
3. Bakalakos EA, Kim JA, Young DC, Martin EW, Jr. Determinants of survival following hepatic resection for metastatic colorectal cancer. World J Surg 1998;22:399-404; discussion -5.
4. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 1996;77:1254-1262
5. Angelopoulos S, Kanellos I, Christophoridis E, Tsachalis T, Kanellou A, Betsis D. Five-year survival after curative resection for adenocarcinoma of the colon. Tech Coloproctol 2004;8 Suppl 1:s152-4. (Pubitemid 40394543)
6. Naitoh T, Tsuchiya T, Honda H, Oikawa M, Saito Y, Hasegawa Y. Clinical outcome of the laparoscopic surgery for stage II and III colorectal cancer. Surg Endosc 2008;22:950-954
7. Orr FW, Wang HH. Tumor cell interactions with the microvasculature: a rate-limiting step in metastasis. Surg Oncol Clin N Am 2001;10:357-381, ix-x.
8. Glinsky VV, Glinsky GV, Glinskii OV, et al. Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. Cancer Res 2003;63:3805-3811
9. Khaldoyanidi SK, Glinsky VV, Sikora L, et al. MDA-MB-435 human breast carcinoma cell homo- and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigen-galectin-3 interactions. J Biol Chem 2003;278:4127-4134 (Pubitemid 36801149)
10. Cooper CR, McLean L, Mucci NR, Poncza P, Pienta KJ. Prostate cancer cell adhesion to quiescent endothelial cells is not mediated by β-1 integrin subunit. Anticancer Res 2000;20:4159-4162 (Pubitemid 32141758)
11. Khodarev NN, Yu J, Labay E, et al. Tumour-endothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cells. J Cell Sci 2003;116:1013-1022 (Pubitemid 36395612)
12. Wong SK, Jalaludin BB, Henderson CJ, et al. Direct tumor invasion in colon cancer: correlation with tumor spread and survival. Dis Colon Rectum 2008;51:1331-1338
13. Talbot IC, Ritchie S, Leighton MH, Hughes AO, Bussey HJ, Morson BC. The clinical significance of invasion of veins by rectal cancer. Br J Surg 1980;67:439-442 (Pubitemid 10059642)
14. Adachi Y, Inomata M, Kakisako K, Sato K, Shiraishi N, Kitano S. Histopathologic characteristics of colorectal cancer with liver metastasis. Dis Colon Rectum 1999;42:1053-1056 (Pubitemid 29383836)
15. Ohji Y, Yao T, Eguchi T, et al. Evaluation of risk of liver metastasis in colorectal adenocarcinoma based on the combination of risk factors including CD10 expression: multivariate analysis of clinicopathological and immunohistochemical factors. Oncol Rep 2007;17:525-530
16. Nanashima A, Yamaguchi H, Sawai T, et al. Expression of adhesion molecules in hepatic metastases of colorectal carcinoma: relationship to primary tumours and prognosis after hepatic resection. J Gastroenterol Hepatol 1999;14:1004-1009 (Pubitemid 29487297)
17. Barozzi C, Ravaioli M, D'Errico A, et al. Relevance of biologic markers in colorectal carcinoma: a comparative study of a broad panel. Cancer 2002;94:647-657 (Pubitemid 34132292)
18. Di Martino E, Wild CP, Rotimi O, Darnton JS, Olliver RJ, Hardie LJ. IGFBP-3 and IGFBP-10 (CYR61) up-regulation during the development of Barrett's oesophagus and associated oesophageal adenocarcinoma: potential biomarkers of disease risk. Biomarkers 2006;11:547-561 (Pubitemid 44614826)
19. Tanami H, Tsuda H, Okabe S, et al. Involvement of cyclin D3 in liver metastasis of colorectal cancer, revealed by genome-wide copy-number analysis. Lab Invest 2005;85:1118-1129 (Pubitemid 43073985)
20. Auerbach R, Alby L, Morrissey LW, Tu M, Joseph J. Expression of organ-specific antigens on capillary endothelial cells. Microvasc Res 1985;29:401-411 (Pubitemid 16158233)
21. Kang Y, Siegel PM, Shu W, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003;3:537-549 (Pubitemid 36808649)
22. Minn AJ, Gupta GP, Siegel PM, et al. Genes that mediate breast cancer metastasis to lung. Nature 2005;436:518-524
23. Okazaki K, Nakayama Y, Shibao K, et al. Establishment of a human colon cancer cell line (PMF-ko14) displaying highly metastatic activity. Int J Oncol 2000;17:39-45.
24. Bayon LG, Izquierdo MA, Sirovich I, van Rooijen N, Beelen RH, Meijer S. Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver. Hepatology 1996;23:1224-1231 (Pubitemid 26137070)
25. Schmitt-Graff A, Desmouliere A, Gabbiani G. Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity. Virchows Arch 1994;425:3-24. (Pubitemid 24295501)
26. Lin MT, Chang CC, Lin BR, et al. Elevated expression of Cyr61 enhances peritoneal dissemination of gastric cancer cells through integrin α2β1. J Biol Chem 2007;282:34594-34604
27. Lu Y, Xiao G, Galson DL, et al. PTHrP-induced MCP-1 production by human bone marrow endothelial cells and osteoblasts promotes osteoclast differentiation and prostate cancer cell proliferation and invasion in vitro. Int J Cancer 2007;121:724-733
28. Hanekom GS, Stubbings HM, Kidson SH. The active fraction of plasmatic plasminogen activator inhibitor type 1 as a possible indicator of increased risk for metastatic melanoma. Cancer Detect Prev 2002;26:50-59
29. Mataraza JM, Li Z, Jeong HW, Brown MD, Sacks DB. Multiple proteins mediate IQGAP1-stimulated cell migration. Cell Signal 2007;19:1857-1865 (Pubitemid 47081378)
30. Nabeshima K, Shimao Y, Inoue T, Koono M. Immunohistochemical analysis of IQGAP1 expression in human colorectal carcinomas: its overexpression in carcinomas and association with invasion fronts. Cancer Lett 2002;176:101-109 (Pubitemid 34085075)
31. Yu LG, Andrews N, Zhao Q, et al. Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion. J Biol Chem 2007;282:773-781 (Pubitemid 47076627)
32. Nagy N, Legendre H, Engels O, et al. Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting. Cancer 2003;97:1849-1858 (Pubitemid 36397258)
33. Wang H, Nemoto-Sasaki Y, Kondo T, Akiyama M, Mukaida N. Potential involvement of monocyte chemoattractant protein (MCP)-1/CCL2 in IL-4-mediated tumor immunity through inducing dendritic cell migration into the draining lymph nodes. Int Immunopharmacol 2003;3:627-642 (Pubitemid 36577291)
34. Kagaya T, Nakamoto Y, Sakai Y, et al. Monocyte chemoattractant protein-1 gene delivery enhances antitumor effects of herpes simplex virus thymidine kinase/ganciclovir system in a model of colon cancer. Cancer Gene Ther 2006;13:357-366
35. Shinohara H, Yano S, Bucana CD, Fidler IJ. Induction of chemokine secretion and enhancement of contact-dependent macrophage cytotoxicity by engineered expression of granulocyte-macrophage colony-stimulating factor in human colon cancer cells. J Immunol 2000;164:2728-2737 (Pubitemid 30115506)
36. Tanaka S, Tatsuguchi A, Futagami S, et al. Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma. Gut 2006;55:54-61. (Pubitemid 41820636)
37. Kim JM, Cho SJ, Oh YK, Jung HY, Kim YJ, Kim N. Nuclear factor-κ B activation pathway in intestinal epithelial cells is amajor regulator of chemokine gene expression and neutrophil migration induced by Bacteroides fragilis enterotoxin. Clin Exp Immunol 2002;130:59-66.
38. Ogunwobi OO, Beales IL. Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells. Regul Pept 2006;134:105-113
39. Vavricka SR, Musch MW, Chang JE, et al. hPepT1 transports muramyl dipeptide, activating NF-κB and stimulating IL-8 secretion in human colonic Caco2/bbe cells. Gastroenterology 2004;127:1401-1409
40. Yang X, Lu P, Ishida Y, Kuziel WA, Fujii C, Mukaida N. Attenuated liver tumor formation in the absence of CCR2 with a concomitant reduction in the accumulation of hepatic stellate cells, macrophages and neovascularization. Int J Cancer 2006;118:335-345 (Pubitemid 41779072)
41. Liu H, Liu W, Wu Y, et al. Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers. Cancer Res 2005;65:7635-7643 (Pubitemid 41297236)
42. Loberg RD, Ying C, Craig M, et al. Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo. Cancer Res 2007;67:9417-9424 (Pubitemid 47535932)
43. Gazzaniga S, Bravo AI, Guglielmotti A, et al. Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft. J Invest Dermatol 2007;127:2031-2041 (Pubitemid 47075380)
44. Singh VK, Zhou Y, Marsh JA, et al. Synuclein-gamma targeting peptide inhibitor that enhances sensitivity of breast cancer cells to antimicrotubule drugs. Cancer Res 2007;67:626-633 (Pubitemid 46192201)